0000002186false--12-31Q320221.00100000000000.6050000000145040041160000.213986871000182361210000540200054020001836886300000183149990001101500205644681500171316000000021862022-01-012022-09-300000002186us-gaap:SubsequentEventMember2022-10-012022-10-270000002186bkti:LawrenceKansasMember2021-03-012021-03-3100000021862020-02-012020-02-280000002186bkti:SawgrassTechnologyParkMember2022-01-012022-09-3000000021862021-03-012021-03-310000002186bkti:LawrenceKansasMember2021-03-3100000021862020-02-280000002186srt:MaximumMemberbkti:CreditAgreementMember2022-01-012022-09-300000002186srt:MinimumMemberbkti:CreditAgreementMember2022-01-012022-09-300000002186bkti:CreditAgreementMember2019-09-012019-09-250000002186bkti:CreditAgreementMember2021-04-012021-04-060000002186bkti:CreditAgreementMember2019-09-250000002186bkti:CreditAgreementMember2021-04-060000002186bkti:CreditAgreementMember2022-01-012022-09-300000002186bkti:CreditAgreementMember2022-09-3000000021862021-01-300000002186bkti:UnitedStatesGovernmentAgenciesMember2021-01-012021-09-300000002186bkti:UnitedStatesGovernmentAgenciesMember2021-07-012021-09-300000002186bkti:UnitedStatesGovernmentAgenciesMember2022-01-012022-09-300000002186bkti:UnitedStatesGovernmentAgenciesMember2022-07-012022-09-300000002186us-gaap:RestrictedStockUnitsRSUMemberbkti:JoshuaHorowitzMember2022-03-012022-03-310000002186us-gaap:RestrictedStockUnitsRSUMemberbkti:JoshuaHorowitzMember2022-04-012022-04-300000002186us-gaap:RestrictedStockUnitsRSUMemberbkti:JoshuaHorowitzMember2022-05-012022-05-310000002186us-gaap:RestrictedStockUnitsRSUMemberbkti:JohnSuzukiMember2022-06-012022-06-080000002186us-gaap:RestrictedStockUnitsRSUMemberbkti:JoshuaHorowitzMember2022-04-012022-06-300000002186us-gaap:RestrictedStockUnitsRSUMemberbkti:JoshuaHorowitzMember2022-09-012022-09-300000002186bkti:LewisJohnsonMember2021-03-040000002186bkti:MrStrubleMember2021-12-170000002186bkti:MrMichaelDillMember2022-09-300000002186bkti:MrMichaelDillMember2022-07-012022-07-3100000021862022-07-012022-07-310000002186us-gaap:RestrictedStockUnitsRSUMember2021-12-310000002186us-gaap:RestrictedStockUnitsRSUMember2022-09-300000002186us-gaap:RestrictedStockUnitsRSUMemberbkti:NonemployeeDirectorMember2021-07-012021-07-300000002186us-gaap:RestrictedStockUnitsRSUMemberbkti:NonemployeeDirectorMember2022-08-012022-08-240000002186us-gaap:RestrictedStockUnitsRSUMemberbkti:NonemployeeDirectorMember2022-08-012022-08-120000002186us-gaap:RestrictedStockUnitsRSUMember2022-04-012022-06-300000002186bkti:EmployeeAndNonemployeeDirectorMember2021-01-012021-09-300000002186bkti:EmployeeAndNonemployeeDirectorMember2021-07-012021-09-300000002186bkti:EmployeeAndNonemployeeDirectorMember2022-01-012022-09-300000002186bkti:EmployeeAndNonemployeeDirectorMember2022-04-012022-06-300000002186us-gaap:RestrictedStockUnitsRSUMember2021-01-012021-09-300000002186bkti:StockOptionsMember2021-01-012021-09-300000002186us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-09-300000002186bkti:StockOptionsMember2022-01-012022-09-300000002186us-gaap:RestrictedStockUnitsRSUMember2021-07-012021-09-300000002186bkti:StockOptionsMember2021-07-012021-09-300000002186bkti:StockOptionsMember2022-07-012022-09-300000002186us-gaap:RestrictedStockUnitsRSUMember2022-07-012022-09-300000002186bkti:TotalMember2022-09-300000002186bkti:TotalMember2021-09-300000002186bkti:TotalMember2022-01-012022-03-310000002186bkti:TotalMember2022-07-012022-09-300000002186bkti:TotalMember2021-07-012021-09-300000002186bkti:TotalMember2021-04-012021-06-300000002186bkti:TotalMember2021-01-012021-03-310000002186bkti:TotalMember2022-04-012022-06-300000002186bkti:TotalMember2022-03-310000002186bkti:TotalMember2022-06-300000002186bkti:TotalMember2021-06-300000002186bkti:TotalMember2021-03-310000002186bkti:TotalMember2020-12-310000002186bkti:TotalMember2021-12-310000002186bkti:TreasuryStocksMember2022-09-300000002186bkti:TreasuryStocksMember2021-09-300000002186bkti:TreasuryStocksMember2022-01-012022-03-310000002186bkti:TreasuryStocksMember2022-07-012022-09-300000002186bkti:TreasuryStocksMember2021-07-012021-09-300000002186bkti:TreasuryStocksMember2021-04-012021-06-300000002186bkti:TreasuryStocksMember2021-01-012021-03-310000002186bkti:TreasuryStocksMember2022-04-012022-06-300000002186bkti:TreasuryStocksMember2022-03-310000002186bkti:TreasuryStocksMember2022-06-300000002186bkti:TreasuryStocksMember2021-06-300000002186bkti:TreasuryStocksMember2021-03-310000002186bkti:TreasuryStocksMember2020-12-310000002186bkti:TreasuryStocksMember2021-12-310000002186bkti:RetainedEarningsAccumulatedDeficitMember2022-09-300000002186bkti:RetainedEarningsAccumulatedDeficitMember2021-09-300000002186bkti:RetainedEarningsAccumulatedDeficitMember2021-01-012021-03-310000002186bkti:RetainedEarningsAccumulatedDeficitMember2021-04-012021-06-300000002186bkti:RetainedEarningsAccumulatedDeficitMember2021-07-012021-09-300000002186bkti:RetainedEarningsAccumulatedDeficitMember2022-01-012022-03-310000002186bkti:RetainedEarningsAccumulatedDeficitMember2022-07-012022-09-300000002186bkti:RetainedEarningsAccumulatedDeficitMember2022-04-012022-06-300000002186bkti:RetainedEarningsAccumulatedDeficitMember2022-03-310000002186bkti:RetainedEarningsAccumulatedDeficitMember2022-06-300000002186bkti:RetainedEarningsAccumulatedDeficitMember2021-06-300000002186bkti:RetainedEarningsAccumulatedDeficitMember2021-03-310000002186bkti:RetainedEarningsAccumulatedDeficitMember2020-12-310000002186bkti:RetainedEarningsAccumulatedDeficitMember2021-12-310000002186bkti:AdditionalPaidCapitalMember2022-09-300000002186bkti:AdditionalPaidCapitalMember2021-09-300000002186bkti:AdditionalPaidCapitalMember2022-01-012022-03-310000002186bkti:AdditionalPaidCapitalMember2022-07-012022-09-300000002186bkti:AdditionalPaidCapitalMember2021-07-012021-09-300000002186bkti:AdditionalPaidCapitalMember2021-04-012021-06-300000002186bkti:AdditionalPaidCapitalMember2021-01-012021-03-310000002186bkti:AdditionalPaidCapitalMember2022-04-012022-06-300000002186bkti:AdditionalPaidCapitalMember2022-03-310000002186bkti:AdditionalPaidCapitalMember2022-06-300000002186bkti:AdditionalPaidCapitalMember2021-06-300000002186bkti:AdditionalPaidCapitalMember2021-03-310000002186bkti:AdditionalPaidCapitalMember2020-12-310000002186bkti:AdditionalPaidCapitalMember2021-12-310000002186bkti:CommonStocksMember2022-09-300000002186bkti:CommonStocksMember2021-09-300000002186bkti:CommonStocksMember2021-07-012021-09-300000002186bkti:CommonStocksMember2021-04-012021-06-300000002186bkti:CommonStocksMember2021-01-012021-03-310000002186bkti:CommonStocksMember2022-01-012022-03-310000002186bkti:CommonStocksMember2022-04-012022-06-300000002186bkti:CommonStocksMember2022-07-012022-09-300000002186bkti:CommonStocksMember2021-06-300000002186bkti:CommonStocksMember2021-03-310000002186bkti:CommonStocksMember2020-12-310000002186bkti:CommonStocksMember2021-12-310000002186bkti:CommonStocksMember2022-03-310000002186bkti:CommonStocksMember2022-06-300000002186bkti:FGFinancialGroupMember2022-01-012022-09-3000000021862021-04-012021-06-3000000021862022-04-012022-06-3000000021862022-06-3000000021862021-01-012021-12-310000002186bkti:BoardOfDirectorsMember2022-09-300000002186bkti:BoardOfDirectorsMember2022-04-060000002186bkti:BoardOfDirectorsMember2022-06-300000002186srt:MaximumMemberbkti:FGFinancialGroupMember2022-01-012022-09-300000002186bkti:FGFinancialGroupMembersrt:MinimumMember2022-01-012022-09-3000000021862021-09-3000000021862020-12-3100000021862021-01-012021-09-3000000021862021-07-012021-09-3000000021862022-07-012022-09-3000000021862021-12-3100000021862022-09-3000000021862022-11-01iso4217:USDxbrli:sharesiso4217:USDxbrli:sharesxbrli:purebkti:integerutr:sqft
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒ QUARTERLY REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT
OF 1934
For the quarterly period ended September 30,
2022
OR
☐ TRANSITION REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
For the transition period from _________ to _________
Commission file number 001-32644
BK TECHNOLOGIES
CORPORATION
|
(Exact name of registrant as specified in its charter)
|
Nevada
|
|
83-4064262
|
(State or other jurisdiction of
|
|
(I.R.S. Employer
|
incorporation or organization)
|
|
Identification No.)
|
7100 Technology Drive
West Melbourne,
Florida 32904
(Address of principal executive offices and Zip Code)
Registrant’s telephone number, including area code: (321)
984-1414
Securities registered pursuant to Section 12(b) of the Act:
Title of Each Class
|
|
Trading Symbol(s)
|
|
Name of Each Exchange on Which Registered
|
Common Stock, par value $0.60 per share
|
|
BKTI
|
|
NYSE American
|
Indicate by check mark whether the registrant: (1) has filed all
reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file
such reports), and (2) has been subject to such filing requirements
for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted
electronically every Interactive Data File required to be submitted
pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter)
during the preceding 12 months (or for such shorter period that the
registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large
accelerated filer, an accelerated filer, a non-accelerated filer, a
smaller reporting company, or an emerging growth company. See the
definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule
12b-2 of the Exchange Act.
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
Non-accelerated Filer
|
☒
|
Smaller reporting company
|
☒
|
|
|
Emerging growth company
|
☐
|
If an emerging growth company, indicate by check mark if the
registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company
(as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
There were 16,984,297 shares of common stock, $0.60 par value, of
the registrant outstanding at November 1, 2022.
TABLE OF CONTENTS
PART I - FINANCIAL
INFORMATION
Item 1. FINANCIAL STATEMENTS
BK TECHNOLOGIES CORPORATION
Condensed Consolidated Balance Sheets
(In thousands, except share data)
|
|
September 30,
2022
|
|
|
December 31,
2021
|
|
|
|
(Unaudited)
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current assets:
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
4,034 |
|
|
$ |
10,580 |
|
Trade accounts receivable, net
|
|
|
5,379 |
|
|
|
8,229 |
|
Inventories, net
|
|
|
26,332 |
|
|
|
16,978 |
|
Prepaid expenses and other current assets
|
|
|
1,711 |
|
|
|
1,634 |
|
Total current assets
|
|
|
37,456 |
|
|
|
37,421 |
|
|
|
|
|
|
|
|
|
|
Property, plant and equipment, net
|
|
|
4,454 |
|
|
|
4,556 |
|
Right-of-use (ROU) asset
|
|
|
2,095 |
|
|
|
2,399 |
|
Investments
|
|
|
773 |
|
|
|
1,795 |
|
Deferred tax assets, net
|
|
|
4,116 |
|
|
|
4,116 |
|
Other assets
|
|
|
144 |
|
|
|
98 |
|
Total assets
|
|
$ |
49,038 |
|
|
$ |
50,385 |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current liabilities:
|
|
|
|
|
|
|
|
|
Accounts payable
|
|
$ |
13,257 |
|
|
$ |
5,883 |
|
Accrued compensation and related taxes
|
|
|
1,461 |
|
|
|
1,099 |
|
Accrued warranty expense
|
|
|
587 |
|
|
|
533 |
|
Accrued other expenses and other current liabilities
|
|
|
772 |
|
|
|
938 |
|
Dividends payable
|
|
|
510 |
|
|
|
505 |
|
Short-term lease liability
|
|
|
476 |
|
|
|
447 |
|
Credit facility
|
|
|
4,458 |
|
|
|
1,470 |
|
Notes payable-current portion
|
|
|
274 |
|
|
|
267 |
|
Deferred revenue
|
|
|
1,029 |
|
|
|
1,045 |
|
Total current liabilities
|
|
|
22,824 |
|
|
|
12,187 |
|
|
|
|
|
|
|
|
|
|
Notes payable, net of current portion
|
|
|
400 |
|
|
|
605 |
|
Long-term lease liability
|
|
|
1,909 |
|
|
|
2,269 |
|
Deferred revenue
|
|
|
2,912 |
|
|
|
2,706 |
|
Total liabilities
|
|
|
28,045 |
|
|
|
17,767 |
|
Commitments and contingencies
|
|
|
|
|
|
|
|
|
Stockholders’ equity:
|
|
|
|
|
|
|
|
|
Preferred stock; $1.00 par value; 1,000,000 authorized
shares; none issued or outstanding
|
|
|
— |
|
|
|
— |
|
Common stock; $0.60 par value; 50,000,000 authorized shares;
18,434,697 and 18,298,999 issued and 16,984,297 and 16,848,599
outstanding shares at September 30, 2022, and December 31, 2021,
respectively
|
|
|
11,061 |
|
|
|
10,979 |
|
Additional paid-in capital
|
|
|
36,352 |
|
|
|
35,862 |
|
Accumulated deficit
|
|
|
(21,018 |
) |
|
|
(8,821 |
) |
Treasury stock, at cost, 1,450,400 shares at September 30, 2022,
and December 31, 2021, respectively
|
|
|
(5,402 |
) |
|
|
(5,402 |
) |
Total stockholders’ equity
|
|
|
20,993 |
|
|
|
32,618 |
|
Total liabilities and stockholders’ equity
|
|
$ |
49,038 |
|
|
$ |
50,385 |
|
See notes to condensed consolidated financial
statements.
BK TECHNOLOGIES CORPORATION
Condensed Consolidated Statements of
Operations
(In thousands, except share and per share data)
(Unaudited)
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 30,
2022
|
|
|
September 30,
2021
|
|
|
September 30,
2022
|
|
|
September 30,
2021
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales, net
|
|
$ |
11,917 |
|
|
$ |
12,626 |
|
|
$ |
30,612 |
|
|
$ |
32,526 |
|
Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of products
|
|
|
9,676 |
|
|
|
8,488 |
|
|
|
25,175 |
|
|
|
20,914 |
|
Selling, general and administrative
|
|
|
4,632 |
|
|
|
4,508 |
|
|
|
14,952 |
|
|
|
13,034 |
|
Total operating expenses
|
|
|
14,308 |
|
|
|
12,996 |
|
|
|
40,127 |
|
|
|
33,948 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss
|
|
|
(2,391 |
) |
|
|
(370 |
) |
|
|
(9,515 |
) |
|
|
(1,422 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other (expense) income:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net interest expense
|
|
|
(30 |
) |
|
|
(19 |
) |
|
|
(70 |
) |
|
|
(37 |
) |
Loss on disposal of property, plant and equipment
|
|
|
— |
|
|
|
(6 |
) |
|
|
— |
|
|
|
(6 |
) |
Gain (loss) on investments
|
|
|
76 |
|
|
|
(2,157 |
) |
|
|
(1,021 |
) |
|
|
310 |
|
Other expense
|
|
|
(57 |
) |
|
|
(14 |
) |
|
|
(66 |
) |
|
|
(59 |
) |
Total other (expense) income
|
|
|
(11 |
) |
|
|
(2,196 |
) |
|
|
(1,157 |
) |
|
|
208 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes
|
|
|
(2,402 |
) |
|
|
(2,566 |
) |
|
|
(10,672 |
) |
|
|
(1,214 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income tax
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(184 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$ |
(2,402 |
) |
|
$ |
(2,566 |
) |
|
$ |
(10,672 |
) |
|
$ |
(1,398 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss per share-basic:
|
|
$ |
(0.14 |
) |
|
$ |
(0.15 |
) |
|
$ |
(0.63 |
) |
|
$ |
(0.10 |
) |
Net loss per share-diluted:
|
|
$ |
(0.14 |
) |
|
$ |
(0.15 |
) |
|
$ |
(0.63 |
) |
|
$ |
(0.10 |
) |
Weighted average shares outstanding-basic
|
|
|
16,950,486 |
|
|
|
16,795,356 |
|
|
|
16,889,554 |
|
|
|
14,307,847 |
|
Weighted average shares outstanding-diluted
|
|
|
16,950,486 |
|
|
|
16,795,356 |
|
|
|
16,889,554 |
|
|
|
14,307,847 |
|
See notes to condensed consolidated financial
statements.
BK TECHNOLOGIES CORPORATION
Condensed Consolidated Statements of Cash
Flows
(In thousands) (Unaudited)
|
|
Nine Months Ended
|
|
|
|
September 30,
2022
|
|
|
September 30,
2021
|
|
Operating activities
|
|
|
|
|
|
|
Net loss
|
|
$ |
(10,672 |
) |
|
$ |
(1,398 |
) |
Adjustments to reconcile net loss net cash used in operating
activities:
|
|
|
|
|
|
|
|
|
Inventories allowances
|
|
|
48 |
|
|
|
572 |
|
Deferred tax expense
|
|
|
— |
|
|
|
184 |
|
Depreciation and amortization
|
|
|
1,061 |
|
|
|
1,033 |
|
Share-based compensation expense-stock options
|
|
|
205 |
|
|
|
215 |
|
Share-based compensation expense-restricted stock units
|
|
|
367 |
|
|
|
162 |
|
Loss (gain) on investments
|
|
|
1,021 |
|
|
|
(310 |
) |
Changes in operating assets and liabilities:
|
|
|
|
|
|
|
|
|
Trade accounts receivable
|
|
|
2,850 |
|
|
|
(1,180 |
) |
Inventories
|
|
|
(9,402 |
) |
|
|
(6,008 |
) |
Prepaid expenses and other current assets
|
|
|
(77 |
) |
|
|
(63 |
) |
Other assets
|
|
|
(46 |
) |
|
|
24 |
|
ROU asset and lease liability
|
|
|
(27 |
) |
|
|
(15 |
) |
Accounts payable
|
|
|
7,374 |
|
|
|
2,401 |
|
Accrued compensation and related taxes
|
|
|
362 |
|
|
|
(113 |
) |
Accrued warranty expense
|
|
|
54 |
|
|
|
(125 |
) |
Deferred revenue
|
|
|
190 |
|
|
|
473 |
|
Accrued other expenses and other current liabilities
|
|
|
(166 |
) |
|
|
529 |
|
Net cash used in operating activities
|
|
|
(6,858 |
) |
|
|
(3,619 |
) |
|
|
|
|
|
|
|
|
|
Investing activities
|
|
|
|
|
|
|
|
|
Purchases of property, plant, and equipment
|
|
|
(959 |
) |
|
|
(1,921 |
) |
Net cash used in investing activities
|
|
|
(959 |
) |
|
|
(1,921 |
) |
|
|
|
|
|
|
|
|
|
Financing activities
|
|
|
|
|
|
|
|
|
Proceeds from common stock issuance, net of costs
|
|
|
— |
|
|
|
11,559 |
|
Cash dividends paid
|
|
|
(1,519 |
) |
|
|
(836 |
) |
Proceeds from the credit facility and notes payable
|
|
|
2,988 |
|
|
|
3,543 |
|
Repayment of the credit facility and notes payable
|
|
|
(198 |
) |
|
|
(1,465 |
) |
Net cash provided by financing activities
|
|
|
1,271 |
|
|
|
12,801 |
|
|
|
|
|
|
|
|
|
|
Net change in cash and cash equivalents
|
|
|
(6,546 |
) |
|
|
7,261 |
|
Cash and cash equivalents, beginning of period
|
|
|
10,580 |
|
|
|
6,826 |
|
Cash and cash equivalents, end of period
|
|
$ |
4,034 |
|
|
$ |
14,087 |
|
|
|
|
|
|
|
|
|
|
Supplemental disclosure
|
|
|
|
|
|
|
|
|
Cash paid for interest
|
|
$ |
93 |
|
|
$ |
37 |
|
Non-cash financing activity
|
|
|
|
|
|
|
|
|
Common stock issued under restricted stock units
|
|
$ |
364 |
|
|
$ |
184 |
|
See notes to condensed consolidated financial
statements.
BK TECHNOLOGIES CORPORATION
Notes to Condensed Consolidated Financial
Statements
Unaudited
(In thousands, except share and per share data and
percentages or as otherwise noted)
1. Condensed Consolidated Financial Statements
Basis of Presentation
The condensed consolidated balance sheet as of September 30, 2022,
the condensed consolidated statements of operations for the three
and nine months ended September 30, 2022 and 2021, and the
condensed consolidated statements of cash flows for the nine months
ended September 30, 2022 and 2021, have been prepared by BK
Technologies Corporation (the “Company,” “we,” “us,” “our”), and
are unaudited. The condensed consolidated balance sheet at December
31, 2021, has been derived from the Company’s audited consolidated
financial statements at that date.
Certain information and footnote disclosures normally included in
financial statements prepared in accordance with accounting
principles generally accepted in the United States of America
(“U.S. GAAP”) have been condensed or omitted. These condensed
consolidated financial statements should be read in conjunction
with the audited consolidated financial statements and notes
thereto included in the Company’s Annual Report on Form 10-K for
the fiscal year ended December 31, 2021, as filed with the
Securities and Exchange Commission (“SEC”) on March 17, 2022, as
amended by filing Form 10-K/A with the SEC on April 29, 2022. The
results of operations for the three and nine months ended September
30, 2022, are not necessarily indicative of the operating results
for a full year.
Principles of Consolidation
The accounts of the Company and its subsidiaries have been included
in the accompanying condensed consolidated financial statements.
All significant intercompany balances and transactions have been
eliminated in consolidation.
The Company consolidates entities in which it has a controlling
financial interest. The Company determines whether it has a
controlling financial interest in an entity by first evaluating
whether the entity is a variable interest entity (“VIE”) or a
voting interest entity.
VIEs are entities in which (i) the total equity investment at risk
is not sufficient to enable the entity to finance its activities
independently, or (ii) the at-risk equity holders do not have the
normal characteristics of a controlling financial interest. A
controlling financial interest in a VIE is present when an
enterprise has one or more variable interests that have both (i)
the power to direct the activities of the VIE that most
significantly impact the VIE’s economic performance, and (ii) the
obligation to absorb losses of the VIE or the right to receive
benefits from the VIE that could potentially be significant to the
VIE. The enterprise with a controlling financial interest is the
primary beneficiary and consolidates the VIE.
Voting interest entities lack one or more of the characteristics of
a VIE. The usual condition for a controlling financial interest is
ownership of a majority voting interest for a corporation or a
majority of kick-out or participating rights for a limited
partnership.
When the Company does not have a controlling financial interest in
an entity but exerts significant influence over the entity’s
operating and financial policies (generally defined as owning a
voting or economic interest of between 20% to 50%), the Company’s
investment is accounted for under the equity method of accounting.
If the Company does not have a controlling financial interest in,
or exert significant influence over, an entity, the Company
accounts for its investment at fair value, if the fair value option
was elected, or at cost.
Through September 30, 2022 the Company was the sole limited partner
in FGI 1347 Holdings, LP, ("1347 LP"), a consolidated VIE. As
disclosed in Note 6, the Company ceased to be the limited partner
of 1347 LP as of September 30, 2022.
Fair Value of Financial Instruments
The Company’s financial instruments consist of cash and cash
equivalents, trade accounts receivable, investments, accounts
payable, accrued expenses, notes payable, credit facilities, and
other liabilities. As of September 30, 2022, and December 31, 2021,
the carrying amount of cash and cash equivalents, trade accounts
receivable, accounts payable, accrued expenses, notes payable, and
other liabilities approximated their respective fair value due to
the short-term nature and maturity of these instruments.
Through September 14, 2022, the Company held an investment in
common stock of FG Financial Group, Inc. made via 1347 LP. The
Company used observable market data assumptions (Level 1 inputs, as
defined in accounting guidance) that it believes market
participants would use in pricing its investment in FGF Financial
Group Inc.
Effective September 14,2022, the Company has an investment in
Series B Common interests of FG Financial Holdings, LLC (“FG
Holdings”). As further discussed in Note 6, the Company records the
investment according to guidance provided by ASC 820 “Fair Value
Measurement”, as the Company does not have a controlling financial
interest in, nor exerts significant influence over he activities of
FG Holdings. The investment in Series B common interests of FG
Holdings is reported using net asset value (“NAV”) of interests
held by the Company at period-end. The NAV is calculated using
the fair value of the underlying stock of FGF held by FG Holdings,
plus uninvested cash, less liabilities, further adjusted through
allocations based on distribution preferences, as defined in the
operating agreement of FG Holdings. The NAV is used as a
practical expedient and has not been classified within the fair
value hierarchy.
Liquidity
The Company incurred operating losses and reported negative cash
flows from operations during 2022 and 2021. The Company’s
operating results have been negatively impacted by the worldwide
shortages of materials, in particular semiconductors and integrated
circuits, extended lead times, and increased costs and inventory
levels for certain components. The Company's current credit
facility expires on January 31, 2023. The Company is in the process
of negotiating a new credit facility (see Note 13). Management
believes that cash and cash equivalents currently available,
combined with anticipated cash to be generated from operations, and
borrowing ability are sufficient to meet the Company’s working
capital requirements in the foreseeable future. The Company
generally relies on cash from operations, commercial debt, and
equity offerings, to the extent available, to satisfy its liquidity
needs and to meet its payment obligations The Company
may engage in public or private offerings of equity or debt
securities to maintain or increase its liquidity and capital
resources (see Note 13). However, financial and economic
conditions, including those resulting from the COVID-19 pandemic
and the current geopolitical tension, could impact our ability to
raise capital or debt financing, if needed, on acceptable terms or
at all.
Recent Accounting Pronouncements
The Company does not discuss recent pronouncements that are not
anticipated to have a material impact on or are unrelated to its
financial condition, results of operations, cash flows or
disclosures.
Change in Accounting Principle
As disclosed in Note 4, on July 1, 2021, the Company changed its
accounting for inventory to burden the material at the time of
purchase receipts. Prior to July 1, 2021, the Company applied the
material burden at the time the inventory was issued to work in
progress.
2. Significant Events and Transactions
Pursuant to the Company’s capital return program, the Company’s
Board of Directors declared a quarterly dividend of $0.03 per share
of the Company’s common stock on September 30, 2022, to
stockholders of record as of October 25, 2022. These dividends will
be paid on November 8, 2022
On June 30, 2022, the Company’s Board of Directors declared a
quarterly dividend of $0.03 per share of the Company’s common stock
to stockholders of record as of July 25, 2022. These dividends were
paid on August 8, 2022.
On April 6, 2022, the Company’s Board of Directors declared a
quarterly dividend of $0.03 per share of the Company’s common stock
to stockholders of record as of May 2, 2022. These dividends were
paid on May 16, 2022.
3. Allowance for Doubtful Accounts
The allowance for doubtful accounts on trade receivables was
approximately $50 on gross trade receivables of $5,429 and $8,279
at September 30, 2022 and December 31, 2021, respectively. This
allowance is used to state trade receivables at a net realizable
value or the amount that the Company estimates will be collected of
the Company’s gross trade receivables.
4. Inventories, Net
On July 1, 2021, the Company changed its accounting for inventory
to burden the material at the time of purchase receipts. Prior to
July 1, 2021, the Company applied the material burden at the time
the inventory was issued to work in progress. The Company believes
that this method improves financial reporting by better reflecting
the current value of inventory on the consolidated balance sheets,
by providing better matching of revenues and expenses. The fiscal
2020 financial statements have been retrospectively adjusted to
apply the new inventory change. The cumulative effect of this
change on periods prior to those presented herein resulted in a net
increase in inventory and a net decrease in accumulated deficit of
approximately $1,104 as of December 31, 2020.
Inventories, which are presented net of allowance for slow moving,
excess, or obsolete inventory, consisted of the following:
|
|
September 30,
2022
|
|
|
December 31,
2021
|
|
Finished goods
|
|
$ |
3,830 |
|
|
$ |
2,335 |
|
Work in process
|
|
|
8,635 |
|
|
|
4,527 |
|
Raw materials
|
|
|
13,867 |
|
|
|
10,116 |
|
|
|
$ |
26,332 |
|
|
$ |
16,978 |
|
Allowances for slow-moving, excess, or obsolete inventory are used
to state the Company’s inventories at the lower of cost or net
realizable value. The allowances were approximately $1,214 at
September 30, 2022, compared with approximately $1,288 at December
31, 2021.
5. Income Taxes
The Company has recorded no tax expense or benefit for the three
and nine months ended September 30, 2022, compared with an income
tax expense of $0 and $184 for the same periods last year.
The Company’s income tax provision is based on management’s
estimate of the effective tax rate for the full year. The tax
provision (benefit) in any period will be affected by, among other
things, permanent, as well as temporary, differences in the
deductibility of certain items, changes in the valuation allowance
related to net deferred tax assets, in addition to changes in tax
legislation. As a result, the Company may experience significant
fluctuations in the effective book tax rate (that is, tax expense
divided by pre-tax book income) from period to period.
As of September 30, 2022, the Company’s net deferred tax assets
totaled approximately $4,116 and were primarily derived from
research and development tax credits, deferred revenue, and net
operating loss carryforwards.
In order to fully utilize the net deferred tax assets, the Company
will need to generate sufficient taxable income in future years.
The Company analyzed all positive and negative evidence to
determine if, based on the weight of available evidence, it is more
likely than not to realize the benefit of the net deferred tax
assets. The recognition of the net deferred tax assets and related
tax benefits is based upon the Company’s conclusions regarding,
among other considerations, estimates of future earnings based on
information currently available and current and anticipated
customers, contracts, and product introductions, as well as
historical operating results and certain tax planning
strategies.
Based on the analysis of all available evidence, both positive and
negative, the Company has concluded that it does not have the
ability to generate sufficient taxable income in the necessary
period to utilize the entire benefit for the deferred tax assets.
Accordingly, the Company established a valuation allowance of
$2,989 and $610 as of September 30, 2022 and December 31, 2021,
respectively. The Company cannot presently estimate what, if any,
changes to the valuation of its deferred tax assets may be deemed
appropriate in the future. If the Company incurs future losses, it
may be necessary to record additional valuation allowance related
to the deferred tax assets recognized as of September 30, 2022.
6. Investments
The Company held an investment in a limited partnership, FGI 1347
Holdings' LP (“1347 LP”), of which the Company was the sole
limited partner. 1347 LP, was established for the purpose of
investing in securities, and its sole primary asset was shares of
FG Financial Group, Inc. (Nasdaq: FGF) (“FGF”). These shares were
purchased in March and May 2018 for approximately $3,741.
Affiliates of Fundamental Global GP, LLC (“FG”), a significant
stockholder of the Company, served as the general partner and
the investment manager of 1347 LP, and the Company was the sole
limited partner. As the sole limited partner, the Company was
entitled to 100% of net assets held by 1347 LP. FG has not received
any management fees or performance fees or expense reimbursement
for its services to the limited partnership arising in connection
with 1347 LP’s operations, as provided by the partnership
agreement, upon approval by the Company’s Board of Directors.
The Company accounted for the investment in FGF, made through 1347
LP, as a consolidated VIE. VIEs are entities in which (i) the total
equity investment at risk is not sufficient to enable the entity to
finance its activities independently, or (ii) the at-risk equity
holders do not have the normal characteristics of a controlling
financial interest. A controlling financial interest in a VIE is
present when an enterprise has one or more variable interests that
have both (i) the power to direct the activities of the VIE that
most significantly impact the VIE’s economic performance, and (ii)
the obligation to absorb losses of the VIE or the right to receive
benefits from the VIE that could potentially be significant to the
VIE. The enterprise with a controlling financial interest is the
primary beneficiary and consolidates the VIE.
On September 14, 2022, FG contributed all of the shares of FGF held
by 1347 LP to FG Holdings, with an approximate value of $945, based
on the published price of FGF stock, in exchange for
Series B Common Interests of FG Holdings, with an equivalent
value. The Company recognized a gain of $76, and a loss of
$850 for the three and nine months ended September 30,
2022. FG Holdings structure provides for preferred A
interests, which accrue preferred return of eight percent per
annum, and also receive an additional 20% of any positive profits
of FG Holdings, as defined.
The investment in the Series B common interests of FG Holdings is
measured using the NAV practical expedient in accordance with ASC
820 Fair Value Measurement and has not been classified within the
fair value hierarchy. FG Holdings invests in common and
preferred stock of FGF (specific company/growth
objective). FG Holdings structure provides for Series A
preferred interests, which accrue return of eight percent per annum
and receive 20% of positive profits with respect to the total
return in the capital provided by the holders of Series A preferred
interests. There is no defined redemption frequency, and
the Company cannot redeem or transfer its investment without a
prior written consent of FG Holdings managers, who are FG
affiliates. Distributions may be made to members at such
times and amounts as determined by the managers, and shall be based
on the most recent NAV. The Company does not have any
unfunded commitments related to this investment.
On September 30, 2022, Series B Common Interests of FG Holdings
were distributed in-kind to the Company as the sole limited partner
of 1347 LP, and the Company consented to withdraw from 1347 LP, as
the limited partner. As a result, the Company recognized a
loss on deconsolidation of 1347 LP of approximately $43.
As of September 30, 2022, the members and affiliates of FG
Holdings, beneficially owned in the aggregate 5,640,467shares of
FGF’s common stock, representing approximately 60.3% of FGF’s
outstanding shares. Additionally, FG and its affiliates constitute
the largest stockholder of the Company. Mr. Kyle Cerminara,
Chairman of the Company’s Board of Directors, is Chief Executive
Officer, Co-Founder and Partner of FG and serves as Chairman of the
Board of Directors of Ballantyne Strong, Inc. , a manager and
majority Series B member in FG Holdings. Mr. Cerminara also serves
as Chairman of the Board of Directors of FGF.
7. Stockholders’ Equity
The changes in condensed consolidated stockholders’ equity for the
three and nine months ended September 30, 2022 and 2021, are as
follows:
|
|
Common
Stock
Shares
|
|
|
Common
Stock
Amount
|
|
|
Additional
Paid-In
Capital
|
|
|
Accumulated
Deficit
|
|
|
Treasury
Stock
|
|
|
Total
|
|
Balance at December 31, 2021
|
|
|
18,298,999 |
|
|
$ |
10,979 |
|
|
$ |
35,862 |
|
|
$ |
(8,821 |
) |
|
$ |
(5,402 |
) |
|
$ |
32,618 |
|
Common stock issued under restricted stock units
|
|
|
16,000 |
|
|
|
10 |
|
|
|
(10 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Share-based compensation expense-stock options
|
|
|
— |
|
|
|
— |
|
|
|
85 |
|
|
|
— |
|
|
|
— |
|
|
|
85 |
|
Share-based compensation expense-restricted stock units
|
|
|
— |
|
|
|
— |
|
|
|
70 |
|
|
|
— |
|
|
|
— |
|
|
|
70 |
|
Net loss
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(3,936 |
) |
|
|
— |
|
|
|
(3,936 |
) |
Balance at March 31, 2022
|
|
|
18,314,999 |
|
|
|
10,989 |
|
|
|
36,007 |
|
|
|
(12,757 |
) |
|
|
(5,402 |
) |
|
|
28,837 |
|
Common stock issued under restricted stock units
|
|
|
53,864 |
|
|
|
32 |
|
|
|
(32 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Share-based compensation expense-stock options
|
|
|
— |
|
|
|
— |
|
|
|
51 |
|
|
|
— |
|
|
|
— |
|
|
|
51 |
|
Share-based compensation expense-restricted stock units
|
|
|
— |
|
|
|
— |
|
|
|
171 |
|
|
|
— |
|
|
|
— |
|
|
|
171 |
|
Common stock dividends ($0.03 per share)
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(1,014 |
) |
|
|
— |
|
|
|
(1,015 |
) |
Net loss
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(4,334 |
) |
|
|
— |
|
|
|
(4,334 |
) |
Balance at June 30, 2022
|
|
|
18,368,863 |
|
|
|
11,021 |
|
|
|
36,197 |
|
|
|
(18,105 |
) |
|
|
(5,402 |
) |
|
|
23,711 |
|
Common stock issued under restricted stock units
|
|
|
65,834 |
|
|
|
40 |
|
|
|
(40 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Share-based compensation expense-stock options
|
|
|
— |
|
|
|
— |
|
|
|
69 |
|
|
|
— |
|
|
|
— |
|
|
|
69 |
|
Share-based compensation expense-restricted stock units
|
|
|
— |
|
|
|
— |
|
|
|
126 |
|
|
|
— |
|
|
|
— |
|
|
|
126 |
|
Common stock dividends ($0.03 per share)
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(511 |
) |
|
|
— |
|
|
|
(511 |
) |
Net loss
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(2,402 |
) |
|
|
— |
|
|
|
(2,402 |
) |
Balance at September 30, 2022
|
|
|
18,434,697 |
|
|
$ |
11,061 |
|
|
$ |
36,352 |
|
|
$ |
(21,018 |
) |
|
$ |
(5,402 |
) |
|
$ |
20,993 |
|
|
|
Common
Stock
Shares
|
|
|
Common
Stock
Amount
|
|
|
Additional
Paid-In
Capital
|
|
|
Accumulated
Deficit
|
|
|
Treasury
Stock
|
|
|
Total
|
|
Balance at December 31, 2020*
|
|
|
13,962,366 |
|
|
$ |
8,377 |
|
|
$ |
26,346 |
|
|
$ |
(5,693 |
) |
|
$ |
(5,402 |
) |
|
$ |
23,628 |
|
Common stock issued under restricted stock units
|
|
|
24,505 |
|
|
|
15 |
|
|
|
(15 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Share-based compensation expense-stock options
|
|
|
— |
|
|
|
— |
|
|
|
32 |
|
|
|
— |
|
|
|
— |
|
|
|
32 |
|
Share-based compensation expense-restricted stock units
|
|
|
— |
|
|
|
— |
|
|
|
103 |
|
|
|
— |
|
|
|
— |
|
|
|
103 |
|
Common stock dividends ($0.02 per share)
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(251 |
) |
|
|
— |
|
|
|
(251 |
) |
Net loss*
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(670 |
) |
|
|
— |
|
|
|
(670 |
) |
Balance at March 31, 2021*
|
|
|
13,986,871 |
|
|
|
8,392 |
|
|
|
26,466 |
|
|
|
(6,614 |
) |
|
|
(5,402 |
) |
|
|
22,842 |
|
Common stock issued, net of issuance costs
|
|
|
4,249,250 |
|
|
|
2,549 |
|
|
|
9,010 |
|
|
|
— |
|
|
|
— |
|
|
|
11,559 |
|
Share-based compensation expense-stock options
|
|
|
— |
|
|
|
— |
|
|
|
33 |
|
|
|
— |
|
|
|
— |
|
|
|
33 |
|
Share-based compensation expense-restricted stock units
|
|
|
— |
|
|
|
— |
|
|
|
25 |
|
|
|
— |
|
|
|
— |
|
|
|
25 |
|
Net income*
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1,838 |
|
|
|
— |
|
|
|
1,838 |
|
Balance at June 30, 2021*
|
|
|
18,236,121 |
|
|
|
10,941 |
|
|
|
35,534 |
|
|
|
(4,776 |
) |
|
|
(5,402 |
) |
|
|
36,297 |
|
Common stock issued under restricted stock units
|
|
|
28,615 |
|
|
|
17 |
|
|
|
(17 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Share-based compensation expense-stock options
|
|
|
— |
|
|
|
— |
|
|
|
150 |
|
|
|
— |
|
|
|
— |
|
|
|
150 |
|
Share-based compensation expense-restricted stock units
|
|
|
— |
|
|
|
— |
|
|
|
34 |
|
|
|
— |
|
|
|
— |
|
|
|
34 |
|
Common stock dividends ($0.02 per share)
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(671 |
) |
|
|
— |
|
|
|
(671 |
) |
Net loss
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(2,566 |
) |
|
|
— |
|
|
|
(2,566 |
) |
Balance at September 30, 2021
|
|
|
18,264,736 |
|
|
$ |
10,958 |
|
|
$ |
35,701 |
|
|
$ |
(8,013 |
) |
|
$ |
(5,402 |
) |
|
$ |
33,244 |
|
*The balances as of December 31, 2020, March 31, 2021, and
June 30, 2021 and the amounts for the three months ended March 31,
2021 and June 30, 2021, have been adjusted to reflect the change in
inventory accounting method, as described in Notes 1 and 4 of the
Condensed Consolidated Financial Statements.
8. Loss Per Share
The following table sets forth the computation of basic and diluted
loss per share:
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 30,
2022
|
|
|
September 30,
2021
|
|
|
September 30,
2022
|
|
|
September 30,
2021
|
|
Numerator:
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss for basic and diluted earnings per share
|
|
$ |
(2,402 |
) |
|
$ |
(2,566 |
) |
|
$ |
(10,672 |
) |
|
$ |
(1,398 |
) |
Denominator for basic loss per share weighted average shares
|
|
|
16,950,486 |
|
|
|
16,795,356 |
|
|
|
16,889,554 |
|
|
|
14,307,847 |
|
Effect of dilutive securities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Options and restricted stock units
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Denominator for diluted loss per share weighted average shares
|
|
|
16,950,486 |
|
|
|
16,795,356 |
|
|
|
16,889,554 |
|
|
|
14,307,847 |
|
Basic loss per share
|
|
$ |
(0.14 |
) |
|
$ |
0.15 |
) |
|
$ |
(0.63 |
) |
|
$ |
(0.10 |
) |
Diluted loss per share
|
|
$ |
(0.14 |
) |
|
$ |
(0.15 |
) |
|
$ |
(0.63 |
) |
|
$ |
(0.10 |
) |
Approximately 1,101,500 stock options and 205,644 restricted stock
units for the three and nine months ended September 30, 2022,
respectively, and 681,500 stock options and 171,316 restricted
stock units for the three and nine months ended September 30, 2021,
respectively, were excluded from the calculation because they were
anti-dilutive.
9. Non-Cash Share-Based Employee Compensation
The Company has an employee and non-employee director share-based
incentive compensation plan. Related to these programs, the Company
recorded non-cash share-based employee compensation expense of $69
and $205 for the three and nine months ended September 30, 2022,
respectively, compared with $150 and $215, for the same periods
last year. The Company considers its non-cash share-based employee
compensation expenses as a component of cost of products and
selling, general and administrative expenses. There was no non-cash
share-based employee compensation expense capitalized as part of
capital expenditures or inventory for the periods presented.
The Company uses the Black-Scholes-Merton option valuation model to
calculate the fair value of stock option grants under this plan.
The non-cash share-based employee compensation expense recorded in
the three and nine months ended September 30, 2022, was calculated
using certain assumptions. Such assumptions are described more
comprehensively in Note 10 (Share-Based Employee Compensation) of
the Notes to the Company’s consolidated financial statements
included in its Annual Report on Form 10-K for the fiscal year
ended December 31, 2021.
A summary of activity under the Company’s stock option plans during
the nine months ended September 30, 2022, is presented below:
|
|
Stock
Options
|
|
|
Wgt. Avg.
Exercise
Price ($)
Per Share
|
|
|
Wgt. Avg.
Remaining
Contractual
Life (Years)
|
|
|
Wgt. Avg.
Grant Date
Fair Value ($)
Per Share
|
|
|
Aggregate
Intrinsic
Value ($)
|
|
As of January 1, 2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding
|
|
|
676,500 |
|
|
|
3.68 |
|
|
|
7.33 |
|
|
|
1.41 |
|
|
|
4,500 |
|
Vested
|
|
|
361,600 |
|
|
|
3.80 |
|
|
|
6.66 |
|
|
|
1.44 |
|
|
|
4,500 |
|
Nonvested
|
|
|
314,900 |
|
|
|
3.53 |
|
|
|
8.10 |
|
|
|
1.39 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Period activity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issued
|
|
|
430,000 |
|
|
|
2.41 |
|
|
|
— |
|
|
|
0.80 |
|
|
|
— |
|
Exercised
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Forfeited
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Expired
|
|
|
5,000 |
|
|
|
4.95 |
|
|
|
— |
|
|
|
1.05 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of September 30, 2022
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding
|
|
|
1,101,500 |
|
|
|
3.18 |
|
|
|
7.78 |
|
|
|
1.18 |
|
|
|
19,375 |
|
Vested
|
|
|
516,233 |
|
|
|
3.64 |
|
|
|
6.50 |
|
|
|
1.37 |
|
|
|
9,167 |
|
Nonvested
|
|
|
585,267 |
|
|
|
2.77 |
|
|
|
8.92 |
|
|
|
1.00 |
|
|
|
10,208 |
|
Restricted Stock Units
On September 30, 2022, the Company granted 9,600 restricted stock
units to Joshua Horowitz for strategic advisory service
compensation. These restricted stock units were fully vested and
settled on the date of grant.
On August 12, 2022, the Company granted to each non-employee
director restricted stock units with a grant-date fair value of $50
per award (resulting in total aggregate grant-date fair value of
$300), which will vest in five equal, annual installments beginning
with the first anniversary of the grant date, subject to the
director’s continued service through such date, provided that, if
the director makes himself available and consents to be nominated
by the Company for continued service as a director, but is not
nominated for the Board of Directors for election by stockholders,
other than for good reason, as determined by the Board of Directors
in its discretion, then the restricted stock units shall vest in
full as of the director’s last date of service as a director of the
Company.
On July 1, 2022, the Company, at the direction of the Board of
Directors, granted on a pro rata basis for 2022 compensation 18,715
and 11,062 restricted stock units to former directors Michael Dill
and Inez Tenenbaum, respectively. These restricted stock units were
fully vested and settled on the date of grant.
On June 30, 2022, the Company granted 3,200 restricted stock units
to Joshua Horowitz for strategic advisory service compensation.
These restricted stock units were fully vested and settled on the
date of grant.
On June 30, 2022, the Company, at the direction of the Board of
Directors, accelerated the vesting of former director Michael
Dill’s unvested restricted stock units granted September 6, 2018,
September 6, 2019, August 24, 2020, and July 30, 2021, and issued
34,264 shares of common stock to Mr. Dill.
On June 8, 2022, the Company, at the direction of the Board of
Directors, granted 10,000 restricted stock units to John Suzuki for
bonus compensation. These restricted stock units were fully vested
and settled on the date of grant.
On May 31, 2022, the Company granted 3,200 restricted stock units
to Joshua Horowitz for strategic advisory service compensation.
These restricted stock units were fully vested and settled on the
date of grant.
On April 30, 2022, the Company granted 3,200 restricted stock units
to Joshua Horowitz for strategic advisory service compensation.
These restricted stock units were fully vested and settled on the
date of grant.
On March 31, 2022, the Company granted 16,000 restricted stock
units to Joshua Horowitz for strategic advisory service
compensation. These restricted stock units were fully vested and
settled on the date of grant.
On December 17, 2021, upon the resignation of former director John
Struble, the Company, at the direction of the Board of Directors,
accelerated the vesting of Mr. Struble’s unvested restricted stock
units granted September 6, 2018, September 6, 2019, August 24,
2020, and July 30, 2021, and issued 34,264 shares of common stock
to Mr. Struble.
On August 24, 2021, the Company granted to each non-employee
director restricted stock units with a grant-date fair value of $40
per award (resulting in total aggregate grant-date fair value of
$240), which will vest in five equal, annual installments beginning
with the first anniversary of the grant date, subject to the
director’s continued service through such date, provided that, if
the director makes himself available and consents to be nominated
by the Company for continued service as a director, but is not
nominated for the Board of Directors for election by stockholders,
other than for good reason, as determined by the Board of Directors
in its discretion, then the restricted stock units shall vest in
full as of the director’s last date of service as a director of the
Company.
On July 30, 2021, the Company granted to each non-employee director
restricted stock units with a grant-date fair value of $50 per
award (resulting in total aggregate grant-date fair value of $250),
which will vest in five equal, annual installments beginning with
the first anniversary of the grant date, subject to the director’s
continued service through such date, provided that, if the director
makes himself available and consents to be nominated by the Company
for continued service as a director, but is not nominated for the
Board of Directors for election by stockholders, other than for
good reason, as determined by the Board of Directors in its
discretion, then the restricted stock units shall vest in full as
of the director’s last date of service as a director of the
Company.
On March 4, 2021, upon the resignation of former director Lewis
Johnson, the Company, at the direction of the Board of Directors,
accelerated the vesting of Mr. Johnson’s unvested restricted stock
units granted September 6, 2018, September 6, 2019, and August 24,
2021, and issued 24,505 shares of common stock to Mr. Johnson.
There were 205,644 and 137,055 restricted stock units outstanding
as of September 30, 2022, and December 31, 2021, respectively.
The Company recorded non-cash restricted stock unit compensation
expense of $126 and $367 for the three and nine months ended
September 30, 2022, respectively, compared with $34 and $162,
respectively for the same periods last year.
A summary of non-vested restricted stock under the Company’s
non-employee director share-based incentive compensation plan is as
follows:
|
|
Number
of Shares
|
|
|
Weighted Average
Price per Share
|
|
Unvested at January 1, 2022
|
|
|
137,055 |
|
|
$ |
3.33 |
|
Granted
|
|
|
204,287 |
|
|
$ |
2.39 |
|
Vested and issued
|
|
|
(135,698 |
) |
|
$ |
2.96 |
|
Cancelled/forfeited
|
|
|
- |
|
|
|
|
|
Unvested at September 30, 2022
|
|
|
205,644 |
|
|
$ |
2.64 |
|
10. Commitments and Contingencies
Legal Matters
From time to time, the Company may be involved in various claims
and legal actions arising in the ordinary course of its business.
On a quarterly basis, the Company assesses its liabilities and
contingencies in connection with outstanding legal proceedings
utilizing the latest information available. Where it is probable
that the Company will incur a loss and the amount of the loss can
be reasonably estimated, it records a liability in its consolidated
financial statements. These legal accruals may be increased or
decreased to reflect any relevant developments on a quarterly
basis. Where a loss is not probable or the amount of the loss is
not estimable, the Company does not accrue legal reserves,
consistent with applicable accounting guidance. There were no
pending material claims or legal matters as of September 30,
2022.
Covid 19 and Geopolitical Tension
In December 2019, a novel strain of the coronavirus (COVID-19)
surfaced in Wuhan, China, which spread globally and was declared a
pandemic by the World Health Organization in March 2020. From that
time, additional variants have surfaced. The COVID-19 pandemic
continues to evolve, impacting the global economy, causing market
instability and uncertainty in the labor market. The full extent of
the impact of the COVID-19 pandemic will depend on future
developments, which are highly uncertain and cannot be predicted at
this time. We will continue to monitor the COVID-19 pandemic as
well as resulting legislative and regulatory changes to manage our
response and assess and mitigate potential adverse impacts to our
business. Even as the COVID-19 pandemic subsides, we may continue
to experience an adverse impact to our business as a result of its
national and global economic impact, including any recession that
may occur in the future.
Additionally, U.S. and global markets and supply chains are
experiencing volatility and disruption following the escalation of
geopolitical tensions and the start of the military conflict
between Russia and Ukraine.
Purchase Commitments
As of September 30, 2022, the Company had purchase commitments for
inventory totaling approximately $13,276.
Significant Customers
Sales to United States government agencies represented
approximately $4,196 (35.2%) and $11,161 (36.4%) of the Company’s
net total sales for the three and nine months ended September 30,
2022, respectively, compared with approximately $6,371 (50.5%) and
$13,237 (39.4%), for the same periods last year. Accounts
receivable from agencies of the United States government were
$1,545 as of September 30, 2022, compared with approximately $5,197
at the same date last year.
11. Debt
BK Technologies, Inc. (“BK Inc.”), a wholly owned subsidiary of the
Company, entered into a $5,000 Credit Agreement and a related Line
of Credit Note (the “Note” and collectively with the Credit
Agreement, the “Credit Agreement”) with JPMorgan Chase Bank, N.A.
(“JPMC”) on January 30, 2021. The Credit Agreement provides for a
revolving line of credit of up to $5,000, with availability under
the line of credit subject to a borrowing base calculated as a
percentage of accounts receivable and inventory. Proceeds of
borrowings under the Credit Agreement may be used for general
corporate purposes. The line of credit is collateralized by a
blanket lien on all personal property of BK Technologies, Inc.,
pursuant to the terms of the Continuing Security Agreement with
JPMC. The Company and each subsidiary of BK Inc. are guarantors of
BK Technologies, Inc.’s obligations under the Credit Agreement, in
accordance with the terms of the Continuing Guaranty. On January
31, 2022, our revolving credit facility, which originated on
January 30, 2020, was extended for one year, through January 31,
2023.
Borrowings under the Credit Agreement will bear interest at the
secured overnight financing rate plus a margin of 2.0%. The line of
credit, as modified, is to be repaid in monthly payments of
interest only, payable in arrears, commencing on February 1, 2022,
with all outstanding principal and interest to be payable in full
at maturity (January 31, 2023). As of September 30, 2022, the
interest rate was 4.879%.
The Credit Agreement contains certain customary restrictive
covenants, including restrictions on liens, indebtedness, loans and
guarantees, acquisitions and mergers, sales of assets, and stock
repurchases by BK Technologies, Inc. The Credit Agreement contains
one financial covenant requiring BK Technologies, Inc., to maintain
a tangible net worth of at least $20,000 at any fiscal quarter
end.
The Credit Agreement provides for customary events of default,
including: (1) failure to pay principal, interest or fees under the
Credit Agreement when due and payable; (2) failure to comply with
other covenants and agreements contained in the Credit Agreement
and the other documents executed in connection therewith; (3) the
making of false or inaccurate representations and warranties; (4)
defaults under other agreements with JPMC or under other debt or
other obligations of BK Technologies, Inc.; (5) money judgments and
material adverse changes; (6) a change in control or ceasing to
operate business in the ordinary course; and (7) certain events of
bankruptcy or insolvency. Upon the occurrence of an event of
default, JPMC may declare the entire unpaid balance immediately due
and payable and/or exercise any and all remedial and other rights
under the Credit Agreement.
BK Technologies, Inc. was in compliance with all covenants under
the Credit Agreement as of September 30, 2022, and the date of
filing this report. As of September 30, 2022, the Company had an
outstanding balance of $4,458, and a net balance availability of
$542 under the Credit Agreement. As of the date of filing this
report, the Company had an outstanding balance of $4,458, and a net
balance availability of $542 under the Credit Agreement.
On April 6, 2021, BK Technologies, Inc., a wholly owned subsidiary
of BK Technologies Corporation, and JPMC, as a lender, entered into
a Master Loan Agreement in the amount of $743 to finance various
items of manufacturing equipment. The loan is collateralized by the
equipment purchased using the proceeds. The Master Loan Agreement
is payable in 48 equal monthly principal and interest payments of
approximately $16 beginning on May 8, 2021, matures on April 8,
2025, and bears a fixed interest rate of 3.0%.
On September 25, 2019, BK Technologies, Inc., a wholly owned
subsidiary of the Company, and U.S. Bank Equipment Finance, a
division of U.S. Bank National Association, as a lender, entered
into a Master Loan Agreement in the amount of $425 to finance
various items of manufacturing equipment. The loan is
collateralized by the equipment purchased using the proceeds. The
Master Loan Agreement is payable in 60 equal monthly principal and
interest payments of approximately $8 beginning on October 25,
2019, matures on September 25, 2024, and bears a fixed interest
rate of 5.11%.
The following table summarizes the notes payable principle
repayments subsequent to September 30, 2022:
|
|
September 30,
2022
|
|
Remaining three months of 2022
|
|
$ |
68 |
|
2023
|
|
|
278 |
|
2024
|
|
|
263 |
|
2025
|
|
|
65 |
|
Total payments
|
|
$ |
674 |
|
12. Leases
The Company accounts for its leasing arrangements in accordance
with Topic 842, “Leases”. The Company leases manufacturing and
office facilities and equipment under operating leases and
determines if an arrangement is a lease at inception. ROU assets
represent the Company’s right to use an underlying asset for the
lease term and lease liabilities represent its obligation to make
lease payments arising from the lease. Operating lease ROU assets
and liabilities are recognized at the lease commencement date based
on the present value of lease payments over the lease term.
As most of its leases do not provide an implicit rate, the Company
uses its incremental borrowing rate based on the information
available at commencement date in determining the present value of
lease payments. The Company’s lease terms may include options to
extend or terminate the lease when it is reasonably certain that
the Company will exercise that option. The Company has lease
agreements with lease and non-lease components, which are accounted
for separately.
The Company leases approximately 54,000 square feet (not in
thousands) of industrial space in West Melbourne, Florida, under a
non-cancellable operating lease. The lease has the expiration date
of September 30, 2027. Annual rental, maintenance and tax expenses
for the facility are approximately $491.
In February 2020, the Company entered into a lease for 6,857 square
feet (not in thousands) of office space at Sawgrass Technology
Park, 1619 NW 136th Avenue in Sunrise, Florida, for a period of 64
months commencing July 1, 2020. Annual rental, maintenance and tax
expenses for the facility will be approximately $196 for the first
year, increasing by approximately 3% for each subsequent 12-month
period.
In March 2021, the Company executed an agreement for the
termination of its lease for 8,100 square feet (not in thousands)
of office space in Lawrence, Kansas, effective March 31, 2021 and
recognized a “Lease Termination” expense of approximately $53. The
original term of the lease was through December 31, 2021.
Lease costs consisted of the following:
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 30,
2022
|
|
|
September 30,
2021
|
|
|
September 30,
2022
|
|
|
September 30,
2021
|
|
Operating lease cost
|
|
$ |
136 |
|
|
$ |
136 |
|
|
$ |
408 |
|
|
$ |
438 |
|
Short-term lease cost
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Variable lease cost
|
|
|
33 |
|
|
|
33 |
|
|
|
99 |
|
|
|
98 |
|
Total lease cost
|
|
$ |
169 |
|
|
$ |
169 |
|
|
$ |
507 |
|
|
$ |
536 |
|
Supplemental cash flow information related to leases was as
follows:
|
|
Three Months Ended
|
|
|
Nine Months Ended
|
|
|
|
September 30,
2022
|
|
|
September 30,
2021
|
|
|
September 30,
2022
|
|
|
September 30,
2021
|
|
Cash paid for amounts included in the measurement of lease
liabilities:
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating cash flows (fixed payments)
|
|
$ |
147 |
|
|
$ |
143 |
|
|
$ |
435 |
|
|
$ |
495 |
|
Operating cash flows (liability reduction)
|
|
$ |
114 |
|
|
$ |
104 |
|
|
$ |
331 |
|
|
$ |
375 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ROU assets obtained in exchange for lease obligations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating leases
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
— |
|
|
$ |
14 |
|
Other information related to operating leases was as follows:
|
|
September 30,
2022
|
|
Weighted average remaining lease term (in years)
|
|
|
4.46 |
|
Weighted average discount rate
|
|
|
5.50 |
% |
Maturity of lease liabilities as of September 30, 2022, were as
follows:
|
|
September 30,
2022
|
|
Remaining three months of 2022
|
|
$ |
148 |
|
2023
|
|
|
595 |
|
2024
|
|
|
608 |
|
2025
|
|
|
618 |
|
2026
|
|
|
479 |
|
Thereafter
|
|
|
242 |
|
Total payments
|
|
|
2,690 |
|
Less: imputed interest
|
|
|
(305 |
) |
Total present value of lease liability
|
|
$ |
2,385 |
|
13. Subsequent events
On
October 27, 2022, the Company entered into a Letter of Intent (the
“LOI”) with Alterna Capital Solutions, LLC for a one-year Line of
Credit with total maximum funding up to $15 million, with an
interest rate of Prime plus 1.85% and other monthly administrative
fees. The proposed line of credit would be an accounts
receivable and inventory financing facility, with the borrowing
base of up to 85% of eligible accounts receivable and up to 75% of
net orderly liquidation value of inventory, not to exceed 100% of
eligible accounts receivable. The Company plans to use the
funds obtained from the Line of Credit to replace the existing
JPMorgan Chase Bank Line of Credit agreement described in Footnote
11 of these condensed consolidated financial statements and for
working capital for the business. The Company cannot guarantee that
the transaction contemplated by the LOI will be consummated on the
terms proposed in the LOI as described above, if at all.
Item 2. MANAGEMENT’S DISCUSSION AND
ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF
OPERATIONS
SPECIAL NOTE CONCERNING
FORWARD-LOOKING STATEMENTS
We believe that it is important to communicate our future
expectations to our security holders and to the public. This
report, therefore, contains statements about future events and
expectations which are “forward-looking statements” within the
meaning of Sections 27A of the Securities Act of 1933 and 21E of
the Securities Exchange Act of 1934 (the “Exchange Act”), including
the statements about our plans, objectives, expectations, and
prospects. You can expect to identify these statements by
forward-looking words such as “may,” “might,” “could,” “would,”
“should,” “will,” “anticipate,” “believe,” “plan,” “estimate,”
“project,” “expect,” “intend,” “seek,” “are encouraged” and other
similar expressions. Any statement contained in this report that is
not a statement of historical fact may be deemed to be a
forward-looking statement. Although we believe that the plans,
objectives, expectations and prospects reflected in or suggested by
our forward-looking statements are reasonable, those statements
involve risks, uncertainties and other factors that may cause our
actual results, performance or achievements to be materially
different from any future results, performance or achievements
expressed or implied by these forward-looking statements, and we
can give no assurance that our plans, objectives, expectations and
prospects will be achieved.
Important factors that might cause our actual results to differ
materially from the results contemplated by the forward-looking
statements are contained in the “Risk Factors” section of and
elsewhere in our Annual Report on Form 10-K for the fiscal year
ended December 31, 2021, and in our subsequent filings with the
Securities and Exchange Commission, and include, among others, the
following:
|
·
|
changes or advances in
technology; |
|
|
|
|
·
|
the success of our land mobile
radio product line; |
|
|
|
|
·
|
successful introduction of new
products and technologies, including our ability to successfully
develop and sell our anticipated new multiband product and other
related products in the planned new BKR Series product line and our
announced SaaS solution; |
|
|
|
|
·
|
competition in the land mobile
radio industry; |
|
|
|
|
·
|
general economic and business
conditions, including federal, state and local government budget
deficits and spending limitations, any impact from a prolonged
shutdown of the U.S. Government, and the ongoing effects of the
COVID-19 pandemic, inflation, supply-chain constraints, ongoing
geopolitical conflicts and related sanctions; |
|
|
|
|
·
|
the availability, terms and
deployment of capital; |
|
|
|
|
·
|
reliance on contract manufacturers
and suppliers; |
|
|
|
|
·
|
risks associated with fixed-price
contracts; |
|
|
|
|
·
|
heavy reliance on sales to agencies
of the U.S. Government and our ability to comply with the
requirements of contracts, laws and regulations related to such
sales; |
|
|
|
|
·
|
allocations by government agencies
among multiple approved suppliers under existing agreements; |
|
|
|
|
·
|
our ability to comply with U.S. tax
laws and utilize deferred tax assets; |
|
|
|
|
·
|
our ability to attract and retain
executive officers, skilled workers and key personnel; |
|
·
|
our ability to manage our
growth; |
|
|
|
|
·
|
our ability to identify potential
candidates and consummate acquisition, disposition or investment
transactions, and risks incumbent to being a noncontrolling
interest stockholder in a corporation; |
|
|
|
|
·
|
the impact of general business
conditions, including those resulting from the COVID-19 pandemic,
inflation, ongoing geopolitical conflicts and related sanctions, on
the companies in which we hold investments; |
|
|
|
|
·
|
impact of our capital allocation
strategy; |
|
|
|
|
·
|
risks related to maintaining our
brand and reputation; |
|
|
|
|
·
|
impact of government
regulation; |
|
|
|
|
·
|
rising health care costs; |
|
|
|
|
·
|
our business with manufacturers
located in other countries, including changes in the U.S.
Government and foreign governments’ trade and tariff policies, as
well as any further impact resulting from the COVID-19 pandemic,
inflation, ongoing geopolitical conflicts and related
sanctions; |
|
|
|
|
·
|
our inventory and debt levels; |
|
|
|
|
·
|
protection of our intellectual
property rights; |
|
|
|
|
·
|
fluctuation in our operating
results and stock price; |
|
|
|
|
·
|
acts of war or terrorism, natural
disasters and other catastrophic events, such as the COVID-19
pandemic; |
|
|
|
|
·
|
any infringement claims; |
|
|
|
|
·
|
data security breaches,
cyber-attacks and other factors impacting our technology
systems; |
|
|
|
|
·
|
availability of adequate insurance
coverage; |
|
|
|
|
·
|
maintenance of our NYSE American
listing; |
|
|
|
|
·
|
risks related to being a holding
company; and |
|
|
|
|
·
|
the effect on our stock price and
ability to raise equity capital through future sales of shares of
our common stock. |
Some of these factors and risks have been, and may further be,
exacerbated by the COVID-19 pandemic and general economic
conditions, including the ongoing military conflict in Ukraine,
such as inflationary pressures and disruptions in the global supply
chain. We assume no obligation to publicly update or revise any
forward-looking statements made in this report, whether as a result
of new information, future events, changes in assumptions or
otherwise, after the date of this report. Readers are cautioned not
to place undue reliance on these forward-looking statements.
Reported dollar amounts in the management’s discussion and analysis
(“MD&A”) section of this report are disclosed in millions or as
whole dollar amounts.
The following discussion and analysis should be read in conjunction
with our condensed consolidated financial statements and notes
thereto appearing elsewhere in this report and the MD&A,
consolidated financial statements and notes thereto appearing in
our Annual Report on Form 10-K for the fiscal year ended December
31, 2021, filed with the SEC on March 17, 2022, as amended by
filing Form 10-K/A with the SEC on April 29, 2022.
Executive Overview
BK Technologies Corporation (NYSE American: BKTI) (together with
its wholly owned subsidiaries, “BK,” the “Company,” “we” or “us”)
is a holding company that, through BK Technologies, Inc., its
operating subsidiary, provides public safety grade communications
products and services which make first responders safer and more
efficient. All operating activities described herein are undertaken
by our operating subsidiary.
In business for over 70 years, BK operates two business units
through its operating subsidiary, BK Technologies, Inc.; Radio and
SaaS.
The Radio business unit designs, manufactures and markets
American-made wireless communications products consisting of
two-way land mobile radios (“LMRs”). Two-way LMRs can be radios
that are hand-held (portable) or installed in vehicles
(mobile).
Generally, BK Technologies-branded products serve the government
markets including but not limited to emergency response, public
safety, United States Department of Agriculture, United States
Department of Homeland Security and military customers of federal,
state and municipal government agencies, as well as various
industrial and commercial enterprises. We believe that our
products and solutions provide superior value by offering a high
specification, ruggedized, durable, reliable, feature rich, Project
25 (P25) compliant radio at a lower cost relative to comparable
offerings.
The SaaS business unit focuses on delivering innovative, public
safety smartphone applications which operate ubiquitously over the
public cellular networks. Our BKRplay branded smartphone
application will offer multiple services which make the first
responder safer and more efficient. When tethered to our radios,
the combined solution will offer more unique capability which
increases the sales reach of our radios.
We were incorporated under the laws of the State of Nevada on
October 24, 1997. We are the resulting corporation from the
reincorporation merger of our predecessor, Adage, Inc., a
Pennsylvania corporation, which reincorporated from Pennsylvania to
Nevada effective as of January 30, 1998. Effective on June 4, 2018,
we changed our corporate name from “RELM Wireless Corporation” to
“BK Technologies, Inc.”
Our principal executive offices and manufacturing facility are
located at 7100 Technology Drive, West Melbourne, Florida 32904 and
our telephone number is (321) 984-1414.
Available Information
Our Internet website address is www.bktechnologies.com. We make
available on our Internet website, free of charge, our Annual
Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current
Reports on Form 8-K, proxy statements and amendments to these
reports as soon as practicable after we file such material with, or
furnish it to, the U.S. Securities and Exchange Commission (the
“SEC”). In addition, our Code of Business Conduct and Ethics, Code
of Ethics for the CEO and Senior Financial Officers, Audit
Committee Charter, Compensation Committee Charter, Nominating and
Governance Committee Charter and other corporate governance
policies are available on our website, under “Investor Relations.”
The information contained on our website is not incorporated by
reference in this report. A copy of any of these materials may be
obtained, free of charge, upon request from our investor relations
department by submitting a written request to
bktechnologies@imsinvestorrelations.com or calling (203) 972-9200.
Additional information regarding our investor relations department
can be found at our website. All reports that the Company files
with or furnishes to the SEC also are available free of charge via
the SEC’s website at http://www.sec.gov.
Impact of COVID-19 Pandemic and Recent Capital Markets
Disruption
In December 2019, a novel strain of the coronavirus (COVID-19)
surfaced, which spread globally and was declared a pandemic by the
World Health Organization in March 2020. In response to the
COVID-19 pandemic, we implemented certain policies at our offices
in accordance with best practices to accommodate, and at times
mandate, social distancing, wearing face masks, and remote work
practices. Among other things, we have invested in employee safety
equipment, additional cleaning supplies and measures, adjusted
production lines and workplaces as necessary and adapted new
processes for interactions with our suppliers and customers to
safely manage our operations. Any employees that test positive for
COVID-19 are quarantined and, if possible, work remotely in
accordance with accepted safety practices until after passing
subsequent testing.
Additionally, U.S. and global markets are experiencing volatility
and disruption following the escalation of geopolitical tensions
and the start of the military conflict between Russia and Ukraine.
On February 24, 2022, a full-scale military invasion of Ukraine by
Russian troops was reported. Although the length and impact of the
ongoing military conflict is highly unpredictable, the conflict in
Ukraine could lead to market disruptions, including significant
volatility in commodity prices, credit and capital markets, as well
as supply chain interruptions. We are continuing to monitor the
situation in Ukraine and globally and assessing its potential
impact on our business.
Furthermore, Russia’s prior annexation of Crimea, recent
recognition of two separatist republics in the Donetsk and Luhansk
regions of Ukraine and subsequent military interventions in Ukraine
have led to sanctions and other penalties being levied by the
United States, European Union and other countries against Russia,
Belarus, the Crimea Region of Ukraine, the so-called Donetsk
People’s Republic, and the so-called Luhansk People’s Republic,
including agreement to remove certain Russian financial
institutions from the Society for Worldwide Interbank Financial
Telecommunication (“SWIFT”) payment system. Additional potential
sanctions and penalties have also been proposed and/or threatened.
Russian military actions and the resulting sanctions could
adversely affect the global economy and financial markets and lead
to instability and lack of liquidity in capital markets,
potentially making it more difficult for us to obtain additional
funds.
The impact to our business in 2022, particularly customer orders,
is not known with certainty. Recently, worldwide shortages of
materials, particularly semiconductors and integrated circuits,
have resulted in limited supplies, extended lead times, and
increased costs and inventory levels for certain components used in
our products. While, generally, we have been able to procure the
material necessary to manufacture our products and fulfill customer
orders, there have been delays and long delivery times within our
supply chain. While the progression and duration of these shortages
is not known with certainty, they may last for several quarters or
years. The impact on our operations of such shortages, or
additional shortages that may surface, is uncertain, but could
potentially impact our future sales, manufacturing operations and
financial results. Continued progression of these circumstances
could result in a decline in customer orders, as our customers
could shift purchases to lower-priced or other perceived value
offerings or reduce their purchases and inventories due to
decreased budgets, reduced access to credit or various other
factors, and impair our ability to manufacture our products, which
could have a material adverse impact on our results of operations
and cash flow. While the current impacts of COVID-19 and ongoing
geopolitical conflicts and related sanctions are reflected in our
results of operations, we cannot at this time separate the direct
impacts of these matters from other factors that cause our
performance to vary from quarter to quarter. The ultimate duration
and impact of the COVID-19 pandemic, the ongoing geopolitical
conflicts and related sanctions on our business, results of
operations, financial condition and cash flows is dependent on
future developments, including the duration and severity of the
pandemic, the duration of the ongoing conflict in Ukraine and
additional sanctions related thereto, and the related length of the
impact on the global economy, which are uncertain and cannot be
predicted at this time. Even after the COVID-19 pandemic has
subsided and geopolitical tensions subside, we may continue to
experience an adverse impact to our business as a result of the
national and, to some extent, global economic impact. Furthermore,
the extent to which our mitigation efforts are successful, if at
all, is not presently ascertainable. However, our results of
operations in future periods may continue to be adversely impacted
by the COVID-19 pandemic, the ongoing geopolitical conflict and
related sanctions, and their negative effects on global economic
conditions.
We may experience fluctuations in our quarterly results, in part,
due to governmental customer spending patterns that are influenced
by government fiscal year-end budgets and appropriations. We may
also experience fluctuations in our quarterly results, in part, due
to our sales to federal and state agencies that participate in
wildland fire-suppression efforts, which may be greater during the
summer season when forest fire activity is heightened. In some
years, these factors may cause an increase in sales for the second
and third quarters, compared with the first and fourth quarters of
the same fiscal year. Such increases in sales may cause quarterly
variances in our cash flow from operations and overall financial
condition.
Third Quarter and Nine Months Summary
Customer demand and orders for our products continued to be strong
during the three and nine months ended September 30, 2022. Supply
chain constraints limited our ability to manufacture the quantities
needed to ship and fulfill all the orders. The State of Florida and
our headquarters location in West Melbourne, Florida, was also
impacted by hurricane Ian in the last week of September, which
impacted our ability to ship product to our customers.
Consequently, these orders were carried in backlog, and we
anticipate fulfilling many of these orders during subsequent
quarters.
Overall, our revenues for the three months ended September 30,
2022, declined somewhat compared with the same period of last year.
For the third quarter 2022, sales decreased 5.6% from the third
quarter last year and 1.6% from the immediately preceding quarter.
The decline in sales for the third quarter brought sales for the
nine-months ended September 30, 2022, within 5.9% of the same
nine-month period last year. Gross profit margins as a percentage
of sales for the third quarter and nine-month periods of 2022
decreased compared with the same periods of last year, generally
reflecting cost increases in materials and freight, and lower
production volumes due to certain electronic
component shortages. Selling, general and administrative
(“SG&A”) expenses for the third quarter of 2022 were 2.8%
higher than the SG&A expenses for the third quarter last year,
while SG&A expenses for the nine-month period ended September
30, 2022, increased 14.7% compared to the same period last year.
The increase in general and administrative expenses is attributed
primarily to corporate and headquarters staffing and strategic
initiatives. These factors yielded operating losses for the three
and nine month periods ended September 30, 2022, that increased
primarily due to supply chain material challenges compared to the
same periods last year.
For the third quarter of 2022, our sales decreased 5.6% to
approximately $11.9 million, compared with approximately $12.6
million for the same quarter last year. For the nine months ended
September 30, 2022, sales totaled approximately $30.6 million,
compared with approximately $32.5 million for the same period last
year.
Gross profit margins as a percentage of sales for the third quarter
of 2022 were approximately 18.8%, compared with 32.8% for the third
quarter last year. For the nine-month period ended September 30,
2022, gross profit margins as a percentage of sales were
approximately 17.8%, compared with 35.7% when compared to the same
periods last year.
SG&A expenses for the third quarter of 2022 totaled
approximately $4.6 million, compared with approximately $4.5
million for the same quarter last year. SG&A expenses for the
first nine months of 2022 increased 14.7% to approximately $15.0
million, compared with approximately $13.0 million for the same
period last year.
For the third quarter of 2022, we recognized an operating loss of
approximately $2.4 million, compared with an operating loss of
approximately $0.4 million for the same quarter last year. For the
nine-month period ended September 30, 2022, our operating loss
totaled approximately $9.5 million, compared with approximately
$1.4 million for the same period last year.
For the third quarter of 2022, we recognized a net realized
and unrealized gain totaling approximately $76 thousand on our
investment in FG Financial Group, Inc. made through FG Financial
Holdings, LLC. This compares with an unrealized loss of
approximately $2.2 million on the investment in FG Financial Group,
Inc. made through FG 1347 Holdings, LP for the third quarter
last year. For the nine-month period ended September 30, 2022, we
recognized net realized and unrealized losses of
approximately $1.0 million, compared with an unrealized gain of
$310 thousand for last year’s nine-month period.
Net loss for the three months ended September 30, 2022, was
approximately $2.4 million ($0.14 per basic and diluted share),
compared with a net loss of approximately $2.6 million ($0.15 per
basic and diluted share) for the same quarter last year. For the
nine months ended September 30, 2022, our net loss totaled
approximately $10.7 million ($0.63 per basic and diluted share),
compared with a net loss of approximately $1.4 million ($0.10 per
basic and diluted share) for the same period last year.
As of September 30, 2022, working capital totaled approximately
$14.6 million, of which approximately $9.4 million was comprised of
cash, cash equivalents and trade receivables. As of December 31,
2021, working capital totaled approximately $25.2 million, of which
approximately $18.8 million was comprised of cash, cash equivalents
and trade receivables.
Results of Operations
As an aid to understanding our operating results for the periods
covered by this report, the following table shows selected items
from our condensed consolidated statements of operations expressed
as a percentage of sales:
|
|
Percentage of Sales Three Months
Ended
|
|
|
Percentage of Sales Nine Months
Ended
|
|
|
|
Sept 30, 2022
|
|
|
Sept 30, 2021
|
|
|
Sept 30, 2022
|
|
|
Sept 30, 2021
|
|
Sales
|
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
100.0 |
% |
|
|
100.0 |
% |
Cost of products
|
|
|
(81.2 |
) |
|
|
(67.2 |
) |
|
|
(82.2 |
) |
|
|
(64.3 |
) |
Gross margin
|
|
|
18.8 |
|
|
|
32.8 |
|
|
|
17.8 |
|
|
|
35.7 |
|
Selling, general and administrative expenses
|
|
|
(38.9 |
) |
|
|
(35.7 |
) |
|
|
(48.9 |
) |
|
|
(40.1 |
) |
Other income (expense), net
|
|
|
(0.1 |
) |
|
|
(17.4 |
) |
|
|
(3.8 |
) |
|
|
0.7 |
|
Loss before income taxes
|
|
|
(20.2 |
) |
|
|
(20.3 |
) |
|
|
(34.9 |
) |
|
|
(3.7 |
) |
Income tax (expense) benefit
|
|
|
(0.0 |
) |
|
|
(0.0 |
) |
|
|
(0.0 |
) |
|
|
(0.6 |
) |
Net loss
|
|
|
(20.2 |
)% |
|
|
(20.3 |
)% |
|
|
(34.9 |
)% |
|
|
(4.3 |
)% |
Net Sales
For the third quarter ended September 30, 2022, net sales decreased
5.6% to approximately $11.9 million, compared with approximately
$12.6 million for the same quarter last year. Sales for the nine
months ended September 30, 2022, totaled approximately $30.6
million, compared with approximately $32.5 million for the
nine-month period last year.
Customer demand and orders for our products continued to be strong,
driving record bookings for the third quarter of 2022. Supply chain
constraints limited our ability to manufacture the quantities
needed to convert the orders into shipments and sales revenue.
Consequently, unshipped orders were carried in backlog, and we
anticipate fulfilling a portion of the orders in backlog during
fourth quarter this year. We are taking steps to manage delays in
the supply chain, including carrying additional inventory of
material and components with limited supplies. Although supply
chain factors may continue to impact shipments during the next
quarter, we anticipate being able to fulfill customer requirements.
The precise impact to sales and shipments for the remainder of
2022, however, cannot be quantified.
Sales for the three months ended September 30, 2022 were attributed
primarily to certain state and local public safety opportunities,
as well as federal wildland fire related agencies. From a product
perspective, the primary contributor to orders and shipments during
the third quarter was our BKR 5000 portable radio and related
accessories. The BKR Series is envisioned as a comprehensive line
of new products, which will include new models in coming quarters.
The timing of developing additional BKR Series products and
bringing them to market could be impacted by various factors,
including potential impacts related to our supply chain and the
COVID-19 pandemic to various electronic component suppliers. BKR
Series products, we believe, should increase our addressable market
by expanding the number of federal and other public safety
customers that may purchase our products. However, the timing and
size of orders from agencies at all levels can be unpredictable and
subject to budgets, priorities, and other factors. Accordingly, we
cannot assure that sales will occur under particular contracts, or
that our sales prospects will otherwise be realized.
While the potential impacts of material shortages, lead-times, the
COVID-19 pandemic, and ongoing geopolitical conflict and related
sanctions in coming months and quarters remain uncertain, such
effects have the potential to adversely impact our customers and
our supply chain. Such negative effects on our customers and
suppliers could adversely affect our future sales, gross profit
margins, operations, and financial results.
Cost of Products and Gross Profit Margin
Gross profit margins as a percentage of sales for the third quarter
ended September 30, 2022 were approximately 18.8%, compared with
32.8% for the same quarter last year. For the nine-month period
ended September 30, 2022, gross profit margins were approximately
17.8%, compared with 35.7% for the same period last year.
Our cost of products and gross profit margins are primarily derived
from material, labor and overhead costs, product mix, manufacturing
volumes and pricing. Gross profit margins for the quarter ended
September 30, 2022 decreased compared with the same period last
year, primarily due to increased material costs, including
electronic components, as well as escalated freight costs, which
yielded sub-optimal absorption of manufacturing overhead costs.
During recent quarters, worldwide shortages of materials, including
semiconductors and integrated circuits, have resulted in limited
supplies, extended lead times and higher costs for certain
components used in our products. Accordingly, we have experienced
delivery delays and increased costs within our supply chain. While
the progression and duration of these shortages is not known with
certainty, we are monitoring a number of critical components for
product cost improvement, but the shortages may last for several
quarters. The impact on our operations of such shortages and
increased product costs is uncertain, but could potentially impact
our future sales, gross profit margins, manufacturing operations
and financial results. We utilize a combination of internal
manufacturing capabilities and contract manufacturing relationships
for production efficiencies and to manage material and labor costs.
While we anticipate continuing to do so in the future, we have
increased and are continuing to increase our utilization of
U.S.-based resources, which provides greater security and control
over our production. We believe that our current manufacturing
capabilities and contract relationships or comparable alternatives
will continue to be available to us. However, we may encounter new
product cost and competitive pricing pressures in the future and
the extent of their impact on gross margins, if any, is
uncertain.
Selling, General and Administrative Expenses
SG&A expenses consist of marketing, sales, commissions,
engineering, product development, management information systems,
accounting, headquarters, and non-cash share-based employee
compensation expenses.
SG&A expenses for the third quarter ended September 30, 2022,
totaled approximately $4.6 million (38.9% of sales), compared with
approximately $4.5 million (35.7% of sales) for the same quarter
last year. For the nine months ended September 30, 2022, SG&A
expenses increased by $2.0 million, or 14.6%, to approximately
$15.0 million (48.9% of sales), compared with approximately $13.0
million (40.1% of sales), for the nine-month period last year.
Engineering and product development expenses for the third quarter
of 2022 totaled approximately $2.1 million (17.9% of sales),
compared with approximately $2.0 million (16.1% of sales) for the
same quarter of last year. For the nine months ended September 30,
2022, engineering and product development expenses totaled
approximately $6.7 million (22.0% of sales), compared with
approximately $6.2 million (18.9% of sales) for the nine-month
period last year. The increase in engineering expenses is
attributed primarily to ongoing product design and development
activities, particularly prototyping, for the new BKR series
radios. Most of these activities are being performed by our
internal engineering team and are their primary focus, combined
with sustaining engineering support of our existing products. The
precise date for developing and introducing new products is
uncertain and can be impacted by, among other things, supply chain
shortages and the potential effects of the COVID-19 pandemic in
coming months and quarters.
Marketing and selling expenses for the third quarter of 2022
totaled approximately $1.1 million (8.7% of sales), compared with
approximately $1.0 million (8.2% of sales) for the third quarter
last year. For the nine months ended September 30, 2022, marketing
and selling expenses increased approximately $0.1 million, or 2.4%,
to approximately $3.1 million (10.2% of sales), compared with
approximately $3.0 million (9.3% of sales). The increase for the
nine-month period ended September 30, 2022 are primarily reflecting
increases in reflect activities in support of anticipated sales
growth from new products and customers.
Other general and administrative expenses for the third quarter
2022 totaled approximately $1.4 million (12.2% of sales), compared
with approximately $1.4 million (11.4% of sales) for the same
quarter last year. For the nine months ended September 30, 2022,
general and administrative expenses totaled approximately $5.1
million (16.6% of sales), compared with approximately $3.8 million
(11.8% of sales) for the nine-month period last year. The increase
in general and administrative expenses for the three and nine month
period ending September 30, 2022 is attributed primarily to
corporate and headquarters staffing and strategic initiatives.
Operating Loss
The operating loss for the third quarter ended September 30, 2022,
totaled approximately $2.4 million (20.1% of sales), compared with
approximately $370 thousand (2.9% of sales) for last year’s third
quarter. For the nine months ended September 30, 2022, our
operating loss totaled approximately $9.5 million (31.1% of sales),
compared with approximately $1.4 million (4.4% of sales) for the
nine-month period last year. The operating loss for the quarter
ended September 30, 2022 is attributed primarily to increased
product costs, which adversely impacted gross profit margins and
increased operating expenses. The operating loss for the nine
months ended September 30, 2022 is primarily attributed to
increased product costs and a decrease in sales, which adversely
impacted gross profit margins and increased operating expenses.
Other (Expense) Income
We recorded net interest expense of approximately $30,000 for the
third quarter ended September 30, 2022, compared with approximately
$19,000 for the third quarter of last year. For the nine months
ended September 30, 2022, net interest expense totaled
approximately $70,000, compared with net interest expense of
approximately $37,000 for the nine-month period last year. Net
interest expense was primarily the result of equipment financing,
our revolving credit facility and lower average cash balances.
For the third quarter ended September 30, 2022, we recognized a net
realized and unrealized gain of approximately $0.1 million on
our investment in FG Financial, compared with an unrealized loss of
approximately $2.2 million in FG Financial Group,
Inc. made through FG 1347 Holdings, LP for the third quarter
last year. For the nine months ended September 30, 2022, we
recognized realized and unrealized losses of
approximately $1.0 million on our investment, compared with an
unrealized gain of approximately $0.3 for the same period last
year.
Income Taxes
We recorded no tax expense or benefit for the quarter ended and for
the nine months ended September 30, 2022, compared with no income
tax provision for the third quarter and an income tax expense of
$184,000 for the nine month period last year.
Our income tax provision is based on management’s estimate of the
effective tax rate for the full year. The tax provision (benefit)
in any period will be affected by, among other things, permanent,
as well as temporary, differences in the deductibility of certain
items, in addition to changes in tax legislation. As a result, we
may experience significant fluctuations in the effective book tax
rate (that is, tax expense divided by pre-tax book income) from
period to period.
As of September 30, 2022, our net deferred tax assets totaled
approximately $4.1 million, and were primarily derived from
research and development tax credits, operating loss carryforwards
and deferred revenue.
In order to fully utilize the net deferred tax assets, we will need
to generate sufficient taxable income in future years. We analyze
all positive and negative evidence to determine if, based on the
weight of available evidence, we are more likely than not to
realize the benefit of the net deferred tax assets. The recognition
of the net deferred tax assets and related tax benefits is based
upon our conclusions regarding, among other considerations,
estimates of future earnings based on information currently
available and current and anticipated customers, contracts, and
product introductions, as well as historical operating results and
certain tax planning strategies.
Based on our analysis of all available evidence, both positive and
negative, we have concluded that we do not have the ability to
generate sufficient taxable income in the necessary period to
utilize the entire benefit for the deferred tax assets.
Accordingly, we established a valuation allowance of $3.0 million
and $0.6 million as of September 30, 2022 and December 31, 2021. We
cannot presently estimate what, if any, changes to the valuation of
our deferred tax assets may be deemed appropriate in the future. If
we incur future losses, it may be necessary to record additional
valuation allowance related to the deferred tax assets recognized
as of September 30, 2022.
Liquidity and Capital Resources
For the nine months ended September 30, 2022, net cash used in
operating activities totaled approximately $6.9 million, compared
with cash used by operating activities of approximately $3.6
million for the same period last year. Cash used in operating
activities for the nine months ended September 30, 2022, was
primarily related to a net loss and increased inventory, which were
partially offset by increased accounts payable, a decrease in
accounts receivable and an unrealized loss in marketable
securities.
For the first nine months of 2022, we had a net loss of
approximately $10.7 million, compared with a net loss of
approximately $1.4 million for the same period last year.
Gross inventories increased during the nine months ended September
30, 2022 by approximately $9.4 million, compared with approximately
$6.0 million for the same period last year. The increases for
inventories were attributed primarily to increased purchases to
account for the limited material and component availability
combined with extended supplier lead-times and planned new product
introductions. Prepaid expenses increased during the nine months
ended September 30, 2022 by approximately $77,000, compared with an
increase of $63,000 for the same period last year. Accounts
receivable decreased approximately $2.9 million during the nine
months ended September 30, 2022, compared with an increase of
approximately $1.2 million for the same period last year. The
decrease was primarily due to lower revenues and higher customer
collections during the nine months ended September 30, 2022.
Accounts payable for the nine months ended September 30, 2022,
increased approximately $7.4 million, compared with an increase of
approximately $2.4 million for the same period last year, primarily
due to increased material and component purchases from suppliers
related in-part to delays and shortages within our supply
chain. Depreciation and amortization totaled approximately
$1.1 million for the nine months ended September 30, 2022, compared
with approximately $1.0 million for the same period last
year. Depreciation and amortization are primarily related to
manufacturing and engineering equipment. The loss
on investments for the nine months ended September 30, 2022,
totaled approximately $1.0 million, compared with an unrealized
gain of approximately $310 thousand for same period last year. For
additional information pertaining to our investments, refer to Note
1 (Condensed Consolidated Financial Statements) and Note 6
(Investments) to the condensed consolidated financial statements
included in this report.
Cash used in investing activities for the nine months ended
September 30, 2022, totaled approximately $1.0 million, compared
with approximately $1.9 million for the same period last year. The
cash used for both periods was attributed primarily to the purchase
of engineering and manufacturing related equipment.
For the nine months ended September 30, 2022, cash of approximately
$1.3 million was provided by financing activities, compared with
cash provided by financing activities of approximately $12.8
million for the same period last year. During the nine months ended
September 30, 2022 we paid quarterly dividends, utilizing
approximately $1.5 million, while for the same period last year, we
paid a quarterly dividend of approximately $0.8 million. During the
nine months ended September 30, 2022, we received proceeds of
approximately $3.0 million from our revolving credit facility and
notes payable compared to $3.5 million for the same period last
year. This was partially offset by loan and revolving credit
facility repayments of approximately $0.2 million for the nine
months ended September 30, 2022 compared to $1.5 million for the
same period last year. For the nine months ended September 30,
2021, we closed a public offering of our common stock, generating
net proceeds of approximately $11.6 million.
On January 31, 2022, our revolving credit facility, which
originated on January 30, 2020, was extended for one year, through
January 31, 2023.
BK Technologies, Inc., our wholly owned subsidiary, entered into
the $5 million Credit Agreement with JPMC. The Credit Agreement
provides for a revolving line of credit of up to $5 million, with
availability under the line of credit subject to a borrowing base
calculated as a percentage of accounts receivable and inventory.
Proceeds of borrowings under the Credit Agreement may be used for
general corporate purposes. The line of credit is collateralized by
a blanket lien on all personal property of BK Technologies, Inc.
pursuant to the terms of the Continuing Security Agreement with
JPMC. BK Technologies Corporation and each subsidiary of BK
Technologies, Inc., are guarantors of the obligations under the
Credit Agreement, in accordance with the terms of the Continuing
Guaranty.
Borrowings under the Credit Agreement will bear interest at the
secured overnight financing rate plus a margin of 2.0%. The line of
credit, as modified, is to be repaid in monthly payments of
interest only, payable in arrears, commencing on February 1, 2022,
with all outstanding principal and interest to be payable in full
at maturity (January 31, 2023).
The Credit Agreement contains certain customary restrictive
covenants, including restrictions on liens, indebtedness, loans and
guarantees, acquisitions and mergers, sales of assets, and stock
repurchases by BK Technologies, Inc. The Credit Agreement contains
one financial covenant requiring BK Technologies, Inc., to maintain
a tangible net worth of at least $20 million at any fiscal quarter
end.
The Credit Agreement provides for customary events of default,
including: (1) failure to pay principal, interest or fees under the
Credit Agreement when due and payable; (2) failure to comply with
other covenants and agreements contained in the Credit Agreement
and the other documents executed in connection therewith; (3) the
making of false or inaccurate representations and warranties; (4)
defaults under other agreements with JPMC or under other debt or
other obligations of BK Technologies, Inc.; (5) money judgments and
material adverse changes; (6) a change in control or ceasing to
operate business in the ordinary course; and (7) certain events of
bankruptcy or insolvency. Upon the occurrence of an event of
default, JPMC may declare the entire unpaid balance immediately due
and payable and/or exercise any and all remedial and other rights
under the Credit Agreement.
BK Technologies, Inc. was in compliance with all covenants under
the Credit Agreement as of September 30, 2022, and the date of
filing this report. As of September 30, 2022, the Company had an
outstanding balance of approximately $4,458 and a net balance
availability of approximately $542 under the Credit Agreement. As
of the date of filing this report, the Company had an outstanding
balance of approximately $4,458, and a net balance availability of
approximately $542 under the Credit Agreement.
On April 6, 2021, BK Technologies, Inc., a wholly owned subsidiary
of BK Technologies Corporation, and JPMC, as a lender, entered into
a Master Loan Agreement in the amount of $743 to finance various
items of manufacturing equipment. The loan is collateralized by the
equipment purchased using the proceeds. The Master Loan Agreement
is payable in 48 equal monthly principal and interest payments of
approximately $16 beginning on May 8, 2021, matures on April 8,
2025, and bears a fixed interest rate of 3.0%.
Our cash and cash equivalents balance at September 30, 2022, was
approximately $4.0 million. We believe these funds, combined with
anticipated cash generated from operations and borrowing
availability under our Credit Agreement, are sufficient to meet our
working capital requirements for the foreseeable future. We may,
depending on a variety of factors, including market conditions for
capital raises, the trading price of our common stock and
opportunities for uses of any proceeds, engage in public or private
offerings of equity or debt securities to increase our capital
resources. However, financial and economic conditions, including
those resulting from the COVID-19 pandemic, could limit our access
to credit and impair our ability to raise capital, if needed, on
acceptable terms or at all. We also face other risks that could
impact our business, liquidity, and financial condition. For a
description of these risks, see “Item 1A. Risk Factors” set forth
in our Annual Report on Form 10-K for the fiscal year ended
December 31, 2021, and “Item 1A. Risk Factors” below in this
report.
Critical Accounting Policies
In response to the Securities and Exchange Commission’s financial
reporting release, FR-60, Cautionary Advice Regarding Disclosure
About Critical Accounting Policies, we have selected for disclosure
our revenue recognition process and our accounting processes
involving significant judgments, estimates and assumptions. These
processes affect our reported revenues and current assets and are,
therefore, critical in assessing our financial and operating
status. We regularly evaluate these processes in preparing our
financial statements. The processes for revenue recognition,
allowance for collection of trade receivables, allowance for excess
or obsolete inventory and income taxes involve certain assumptions
and estimates that we believe to be reasonable under present facts
and circumstances. These estimates and assumptions, if incorrect,
could adversely impact our operations and financial position.
There were no changes to our critical accounting policies during
the nine months ended September 30, 2022.
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES
ABOUT MARKET RISK.
As a “smaller reporting company” as defined by Item 229.10(f)(1) of
Regulation S-K, the Company is not required to include the
disclosure under this Item.
Item 4. CONTROLS AND
PROCEDURES
Evaluation of Disclosure Controls and
Procedures
We maintain disclosure controls and procedures (as defined in Rules
13a-15(c) and 15d-15(e) under the Exchange Act) that are designed
to ensure that information required to be disclosed in our reports
under the Exchange Act, is recorded, processed, summarized and
reported within the time periods specified in the SEC’s rules and
forms, and that such information is accumulated and communicated to
our management, including our Chief Executive Officer (who serves
as our principal executive officer) and Chief Financial Officer
(who serves as our principal financial and accounting officer), as
appropriate, to allow timely decisions regarding required
disclosure.
We carried out an evaluation, under the supervision and with the
participation of our management, including our Chief Executive
Officer (principal executive officer) and Chief Financial Officer
(principal financial officer), of the effectiveness of our
disclosure controls and procedures (as defined in Rules 13a-15(e)
and 15d-15(e) under the Exchange Act), as of the end of the period
covered by this Quarterly Report. Based upon that evaluation, our
Chief Executive Officer and Chief Financial Officer concluded that
our disclosure controls and procedures were effective as of the end
of the period covered by this Quarterly Report to ensure that
information required to be disclosed by us in the reports that we
file or submit under the Exchange Act is recorded, processed,
summarized and reported within the time periods specified in the
Securities Exchange Commission’s rules and forms, and that such
information is accumulated and communicated to our management,
including each of such officers as appropriate to allow timely
decisions regarding required disclosure.
Changes in Internal Control over Financial
Reporting
During the three months ended September 30, 2022, there were no
changes in our internal control over financial reporting that have
materially affected, or are reasonably likely to materially affect,
our internal control over financial reporting.
PART II - OTHER INFORMATION
Item 1A. RISK FACTORS
As of the date of this filing, except as set forth herein, there
have been no material changes to the Risk Factors included in our
Annual Report on Form 10-K for the fiscal year ended December 31,
2021, filed with the SEC on March 17, 2022, as amended by filing
Form 10-K/A with the SEC on April 29, 2022 (the “2021 Form 10-K”).
The Risk Factors set forth in the 2021 Form 10-K should be read
carefully in connection with evaluating our business and in
connection with the forward-looking statements contained in this
Quarterly Report on Form 10-Q. Any of the risks described in the
2021 Form 10-K, could materially adversely affect our business,
financial condition or future results and the actual outcome of
matters as to which forward-looking statements are made. These are
not the only risks we face. Additional risks and uncertainties not
currently known to us or that we currently deem to be immaterial
also may materially adversely affect our business, financial
condition and/or operating results.
Item 2. UNREGISTERED SALES OF EQUITY SECURITIES
AND USE OF PROCEEDS
Dividend Restrictions
On January 31, 2022, BK Technologies, Inc., our wholly owned
operating subsidiary, extended its Credit Agreement with JPMC. The
Credit Agreement contains limitations and covenants that may limit
BK Technologies, Inc.’s ability to take certain actions, including
paying dividends to the Company.
Share Repurchase Program
On December 21, 2021, the Company announced that the Board has
authorized a share repurchase program which permits the Company to
purchase up to an aggregate of $5 million of its common shares. The
program does not have an expiration date. Any repurchases would be
funded using cash on hand and cash from operations. The actual
timing, manner and number of shares repurchased under the program
will be determined by management and the Board of Directors at
their discretion, and will depend on several factors, including the
market price of the Company’s common shares, general market and
economic conditions, alternative investment opportunities, and
other business considerations in accordance with applicable
securities laws and exchange rules. The authorization of the share
repurchase program does not require BK Technologies to acquire any
particular number of shares and repurchases may be suspended or
terminated at any time at the Company’s discretion. The following
table provides information about purchases made by us of our common
stock for each month included in the third quarter of 2022:
ISSUER PURCHASES OF EQUITY SECURITIES
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Period
|
|
Total Number of Shares Purchased
|
|
|
Average Price Paid Per Share
|
|
|
Total Number of Shares Purchased as Part of Publicly
Announced Plans or Programs
|
|
|
Approximate Dollar Value of Shares that May Still be
Purchased Under the Plans or Programs
|
|
July 1–31, 2022
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
$ |
5,000,000 |
|
August 1–31, 2022
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
$ |
5,000,000 |
|
September 1–30, 2022
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
$ |
5,000,000 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended September 30, 2022
|
|
|
— |
|
|
$ |
— |
|
|
|
— |
|
|
$ |
5,000,000 |
|
Item 6. EXHIBITS
Exhibits required to be filed by Item 601 of Regulation S-K are
listed in the Exhibit Index below.
Exhibit
Index
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
|
BK TECHNOLOGIES CORPORATION
|
|
|
(The “Registrant”)
|
|
|
|
|
|
Date: November 4, 2022
|
By:
|
/s/ John M. Suzuki
|
|
|
|
John M. Suzuki
Chief Executive Officer
(Principal executive officer and duly
authorized officer)
|
|
|
|
|
|
Date: November 4, 2022
|
By:
|
/s/ Scott A. Malmanger
|
|
|
|
Scott A. Malmanger
Interim Chief Financial Officer
(Principal financial and accounting
officer and duly authorized officer)
|
|
BK Technologies (AMEX:BKTI)
Historical Stock Chart
From Feb 2023 to Mar 2023
BK Technologies (AMEX:BKTI)
Historical Stock Chart
From Mar 2022 to Mar 2023